RIA Novosti covers the readiness of PROMOMED to produce a drug effective in the treatment of COVID-19

Promomed 08 May 2020
Specialists of the pharmaceutical company Promomed have developed their own technology for the full cycle production of antiviral drug favipiravir at the Biokhimik plant in Saransk. This drug demonstrated high efficacy in the fight against a new coronavirus infection, for example, in China.  

Minister of Health Mikhail Murashko confirmed that the first results of clinical trials of the drug showed encouraging results.
Marina Penkova, General Director of the company, told RIA correspondent about the details of the production of domestic favipiravir:

ria.ru